Search
Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus
… fda-science-forum/characterizing-phage-resistance-mutations-vancomycin-resistant-enterococcus … Office of the … spp. Our group has identified several mutants of Vancomycin resistant Enterococcus that have acquired … strain … Characterizing Phage Resistance Mutations in Vancomycin Resistant Enterococcus …
Immunological and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization
… cal-and-microbial-responses-bacteriophage-therapy-targeting-vancomycin-resistant … Office of the Commissioner … … and Microbial Responses to Bacteriophage Therapy Targeting Vancomycin-Resistant Enterococcus Colonization …
Coronavirus (COVID-19) Update: November 23, 2021
… the FDA approved an abbreviated new drug application for vancomycin hydrochloride for injection , indicated to treat … or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. The side effects of vancomycin hydrochloride for injection include diarrhea, …
Fecal Microbiota for Transplantation: Safety Communication- Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms
… beta-lactamase (ESBL)-producing Enterobacteriaceae, vancomycin-resistant enterococci (VRE), carbapenem-resistant …
Antimicrobial Resistance Information from FDA
… Enterococcus faecalis . In addition, claims for testing vancomycin-resistant E. faecalis were added due to FDA … fluoroquinolones, penicillins, sulfonamides, trimethoprim, vancomycin) among 19 organism species for a total of 117 … 2021: FDA approved an abbreviated new drug application for vancomycin hydrochloride for injection, indicated to treat …
Assessment of Safety and Efficacy of Fecal Microbiota for Transplantation Products - 12/10/2020 - 12/10/2020
… caused by the enteric pathogens Clostridium difficile and Vancomycin resistant Enterococcus (VRE) species. Laboratory …
FDA Approves New Antibiotic for Three Different Uses
https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses
… 679 subjects to receive either Zevtera (335 subjects) or vancomycin plus aztreonam [the comparator] (344 subjects). …
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
… (Tempe, Arizona), Keith Lindor, phase 2 study of oral vancomycin for the treatment of primary sclerosing …
FDA In Brief
… with eye injections of compounded drugs containing vancomycin September 2017 09/28/2017 FDA issues guidance to …